Growth hormone as a new treatment modality for short children with chronic renal failure

被引:8
作者
Mehls, O
Haffner, D
Wuhl, E
Tonshoff, B
Schaefer, F
Heinrich, U
Bittner, K
Ehrich, JHH
Filler, G
Gellermann, J
Hampel, H
Bachmann, H
Ruder, H
Bonzel, KE
Scheller, B
Dippell, J
Zimmerhackl, LB
Kreuder, J
Rascher, W
MullerWiefel, DE
Misselwitz, J
Ronnefarth, B
Querfeld, U
Eichstadt, H
Greiner, C
Keller, E
Weber, HP
Heise, HR
Wiemann, D
Beetz, R
Sasse, D
Soergel, M
Pistor, K
Zlotkowski, A
Klare, B
Eife, R
KuwertzBroking, E
Wigger, M
Mix, M
Eicher, O
机构
[1] Division of Pediatric Nephrology, University Children’s Hospital of Heidelberg
关键词
chronic renal failure; dialysis; renal transplantation; growth failure; growth hormone;
D O I
10.1159/000185028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recombinant human growth hormone (rhGH) has become a new treatment modality for short children with chronic renal failure (CRF) and after renal transplantation. The rationale for high-dose rhGH treatment is the insensitivity of the uremic organism to GH. As the insensitivity to GH is expressed more in end-stage renal failure than in earlier stages of CRF, patients on dialysis respond less to rhGH. In transplanted children, rhGH can counterbalance the growth-depressing effects of corticosteroids, In prepubertal children, rhGH improves the height standard deviation score by a mean of +2 within 5 years. The effect of rhGH treatment on final height remains to be studied.
引用
收藏
页码:230 / 235
页数:6
相关论文
共 54 条
[21]  
INGULLI E, 1994, PEDIAT RENAL TRANSPL, P221
[22]  
JOHANSSON G, 1990, ACTA PAEDIATR SCAND, P36
[23]  
JUX C, 1996, IN PRESS 10 INT C EN
[24]   ACCELERATED-GROWTH AFTER RECOMBINANT HUMAN GROWTH-HORMONE TREATMENT OF CHILDREN WITH CHRONIC RENAL-FAILURE [J].
KOCH, VH ;
LIPPE, BM ;
NELSON, PA ;
BOECHAT, MI ;
SHERMAN, BM ;
FINE, RN .
JOURNAL OF PEDIATRICS, 1989, 115 (03) :365-371
[25]   DEXAMETHASONE INHIBITS GROWTH-HORMONE INDUCTION OF INSULIN-LIKE GROWTH FACTOR-I (IGF-I) MESSENGER RIBONUCLEIC-ACID (MESSENGER-RNA) IN HYPOPHYSECTOMIZED RATS AND REDUCES IGF-I MESSENGER-RNA ABUNDANCE IN THE INTACT RAT [J].
LUO, JM ;
MURPHY, LJ .
ENDOCRINOLOGY, 1989, 125 (01) :165-171
[26]   GROWTH-HORMONE, INSULIN-LIKE GROWTH FACTOR-I, AND BENIGN INTRACRANIAL HYPERTENSION [J].
MALOZOWSKI, S ;
TANNER, LA ;
WYSOWSKI, D ;
FLEMING, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (09) :665-666
[27]   GROWTH-RESPONSE TO RECOMBINANT HUMAN GROWTH-HORMONE IN SHORT PREPUBERTAL CHILDREN WITH CHRONIC-RENAL-FAILURE WITH OR WITHOUT DIALYSIS [J].
MEHLS, O ;
BROYER, M ;
ALBERTSSONWIKLAND, K ;
ALLEN, B ;
BAUR, L ;
BEETZ, R ;
BERG, U ;
BONZEL, K ;
CARRASCOSA, A ;
COWELL, C ;
CRAWFORD, B ;
DAVIN, JC ;
DELVALLE, CJ ;
DIPPELL, J ;
GARCIA, L ;
GASKIN, K ;
HAFFNER, D ;
HODSON, EM ;
JANSSEN, F ;
JODAL, U ;
JUREIDINI, K ;
KLARE, B ;
KNIGHT, F ;
KUWERTZBROCKING, E ;
LORIS, C ;
MAES, M ;
MUELLERWIEFEL, DE ;
NAVARRO, M ;
PENFOLD, J ;
PISTOR, K ;
PREECE, M ;
RAPPAPORT, R ;
RASHER, W ;
REES, L ;
RIGDEN, SPA ;
RIVASCRESPO, M ;
ROY, LP ;
RUDER, H ;
SASSE, D ;
SILINK, M ;
SIPILA, I ;
STREHLAN, J ;
STUBBE, P ;
TONSHOFF, B ;
VANDERSCHUERENLODEWEYCKX, M ;
WEBER, HP ;
WUHL, E ;
ZIMMERHACKL, L .
ACTA PAEDIATRICA, 1994, 83 :81-87
[28]   SOMATOMEDIN ACTIVITY AND INORGANIC SULFATE IN CHILDREN UNDERGOING HEMODIALYSIS [J].
PHILLIPS, LS ;
PENNISI, AJ ;
BELOSKY, DC ;
UITTENBOGAART, C ;
ETTENGER, RB ;
MALEKZADEH, MH ;
FINE, RN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 46 (01) :165-168
[29]   PLASMA GROWTH HORMONE-BINDING ACTIVITY IS LOW IN UREMIC CHILDREN [J].
POSTELVINAY, MC ;
TAR, A ;
CROSNIER, H ;
BROYER, M ;
RAPPAPORT, R ;
TONSHOFF, B ;
MEHLS, O .
PEDIATRIC NEPHROLOGY, 1991, 5 (04) :545-547
[30]   SERUM CONCENTRATIONS OF INSULIN-LIKE GROWTH-FACTOR (IGF)-1, IGF-2 AND UNSATURATED SOMATOMEDIN CARRIER PROTEINS IN CHILDREN WITH CHRONIC-RENAL-FAILURE [J].
POWELL, DR ;
ROSENFELD, RG ;
SPERRY, JB ;
BAKER, BK ;
HINTZ, RL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 10 (04) :287-292